402 related articles for article (PubMed ID: 32152607)
1. An open-source drug discovery platform enables ultra-large virtual screens.
Gorgulla C; Boeszoermenyi A; Wang ZF; Fischer PD; Coote PW; Padmanabha Das KM; Malets YS; Radchenko DS; Moroz YS; Scott DA; Fackeldey K; Hoffmann M; Iavniuk I; Wagner G; Arthanari H
Nature; 2020 Apr; 580(7805):663-668. PubMed ID: 32152607
[TBL] [Abstract][Full Text] [Related]
2. VirtualFlow Ants-Ultra-Large Virtual Screenings with Artificial Intelligence Driven Docking Algorithm Based on Ant Colony Optimization.
Gorgulla C; Çınaroğlu SS; Fischer PD; Fackeldey K; Wagner G; Arthanari H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071676
[TBL] [Abstract][Full Text] [Related]
3. Accounting of Receptor Flexibility in Ultra-Large Virtual Screens with VirtualFlow Using a Grey Wolf Optimization Method.
Gorgulla C; Fackeldey K; Wagner G; Arthanari H
Supercomput Front Innov; 2020 Nov; 7(3):4-12. PubMed ID: 34693068
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning.
Shimizu Y; Yonezawa T; Sakamoto J; Furuya T; Osawa M; Ikeda K
Sci Rep; 2021 Apr; 11(1):7420. PubMed ID: 33795749
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Virtual Screening.
Li Q; Shah S
Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
[TBL] [Abstract][Full Text] [Related]
7. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
Davies TG; Wixted WE; Coyle JE; Griffiths-Jones C; Hearn K; McMenamin R; Norton D; Rich SJ; Richardson C; Saxty G; Willems HM; Woolford AJ; Cottom JE; Kou JP; Yonchuk JG; Feldser HG; Sanchez Y; Foley JP; Bolognese BJ; Logan G; Podolin PL; Yan H; Callahan JF; Heightman TD; Kerns JK
J Med Chem; 2016 Apr; 59(8):3991-4006. PubMed ID: 27031670
[TBL] [Abstract][Full Text] [Related]
8. Mining Natural Products for Macrocycles to Drug Difficult Targets.
Begnini F; Poongavanam V; Over B; Castaldo M; Geschwindner S; Johansson P; Tyagi M; Tyrchan C; Wissler L; Sjö P; Schiesser S; Kihlberg J
J Med Chem; 2021 Jan; 64(2):1054-1072. PubMed ID: 33337880
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
[TBL] [Abstract][Full Text] [Related]
10. FINDSITE(comb): a threading/structure-based, proteomic-scale virtual ligand screening approach.
Zhou H; Skolnick J
J Chem Inf Model; 2013 Jan; 53(1):230-40. PubMed ID: 23240691
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking.
Gentile F; Yaacoub JC; Gleave J; Fernandez M; Ton AT; Ban F; Stern A; Cherkasov A
Nat Protoc; 2022 Mar; 17(3):672-697. PubMed ID: 35121854
[TBL] [Abstract][Full Text] [Related]
12. Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein-Protein Interaction.
Zhang Y; Shi Z; Zhou Y; Xiao Q; Wang H; Peng Y
J Med Chem; 2020 Aug; 63(15):7986-8002. PubMed ID: 32233486
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Molecular Details of Keap1-Nrf2 Inhibitors Using Molecular Dynamics and Umbrella Sampling Techniques.
Londhe AM; Gadhe CG; Lim SM; Pae AN
Molecules; 2019 Nov; 24(22):. PubMed ID: 31726716
[TBL] [Abstract][Full Text] [Related]
14. Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors.
Leung CH; Zhang JT; Yang GJ; Liu H; Han QB; Ma DL
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509940
[TBL] [Abstract][Full Text] [Related]
15. A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual Screening.
Gorgulla C; Padmanabha Das KM; Leigh KE; Cespugli M; Fischer PD; Wang ZF; Tesseyre G; Pandita S; Shnapir A; Calderaio A; Gechev M; Rose A; Lewis N; Hutcheson C; Yaffe E; Luxenburg R; Herce HD; Durmaz V; Halazonetis TD; Fackeldey K; Patten JJ; Chuprina A; Dziuba I; Plekhova A; Moroz Y; Radchenko D; Tarkhanova O; Yavnyuk I; Gruber C; Yust R; Payne D; Näär AM; Namchuk MN; Davey RA; Wagner G; Kinney J; Arthanari H
ChemRxiv; 2020 Jul; ():. PubMed ID: 33200116
[TBL] [Abstract][Full Text] [Related]
16. LIGSIFT: an open-source tool for ligand structural alignment and virtual screening.
Roy A; Skolnick J
Bioinformatics; 2015 Feb; 31(4):539-44. PubMed ID: 25336501
[TBL] [Abstract][Full Text] [Related]
17. Fragment-based drug discovery and its application to challenging drug targets.
Price AJ; Howard S; Cons BD
Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
[TBL] [Abstract][Full Text] [Related]
18. Thermodynamic profiling of inhibitors of Nrf2:Keap1 interactions.
Nasiri HR; Linge S; Ullmann D
Bioorg Med Chem Lett; 2016 Jan; 26(2):526-529. PubMed ID: 26653613
[TBL] [Abstract][Full Text] [Related]
19. RASPELD to Perform High-End Screening in an Academic Environment toward the Development of Cancer Therapeutics.
Wolle P; Weisner J; Keul M; Landel I; Lategahn J; Rauh D
ChemMedChem; 2018 Oct; 13(19):2065-2072. PubMed ID: 30079978
[TBL] [Abstract][Full Text] [Related]
20. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
